Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1Neoplasms 1Cancer Pain 1

Interventions

Dexamethasone 11Aprepitant 8Olanzapine 5ramosetron 4Palonosetron 4fosaprepitant 3Ondansetron 3Granisetron 3netupitant, palosentron drug combination 2Tropisetron 2Calcium Dobesilate 2netupitant 1lerisetron 1dexamethasone 21-phosphate 1Transcranial Direct Current Stimulation 1Tablets 1Serotonin 5-HT3 Receptor Antagonists 1Radiotherapy 1Paclitaxel 1Music Therapy 1Metoclopramide 1Megestrol Acetate 1Megestrol 1Gelatin 1Dronabinol 1Dosage Forms 1Carboplatin 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Vomiting × Dronabinol × Clear all
NCT05272865 2023-02-01

Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

LaSanta S A S

Phase 1/2 Unknown
334 enrolled

Cancer Pain, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡